Literature DB >> 16696458

Analytic IMRT dose calculations utilizing Monte Carlo to predict MLC fluence modulation.

I B Mihaylov1, F A Lerma, Y Wu, J V Siebers.   

Abstract

A hybrid dose-computation method is designed which accurately accounts for multileaf collimator (MLC)-induced intensity modulation in intensity modulated radiation therapy (IMRT) dose calculations. The method employs Monte Carlo (MC) modeling to determine the fluence modulation caused by the delivery of dynamic or multisegmental (step-and-shoot) MLC fields, and a conventional dose-computation algorithm to estimate the delivered dose to a phantom or a patient. Thus, it determines the IMRT fluence prediction accuracy achievable by analytic methods in the limit that the analytic method includes all details of the MLC leaf transport and scatter. The hybrid method is validated and benchmarked by comparison with in-phantom film dose measurements, as well as dose calculations from two in-house, and two commercial treatment planning system analytic fluence estimation methods. All computation methods utilize the same dose algorithm to calculate dose to a phantom, varying only in the estimation of the MLC modulation of the incident photon energy fluence. Gamma analysis, with respect to measured two-dimensional (2D) dose planes, is used to benchmark each algorithm's performance. The analyzed fields include static and dynamic test patterns, as well as fields from ten DMLC IMRT treatment plans (79 fields) and five SMLC treatment plans (29 fields). The test fields (fully closed MLC, picket fence, sliding windows of different size, and leaf-tip profiles) cover the extremes of MLC usage during IMRT, while the patient fields represent realistic clinical conditions. Of the methods tested, the hybrid method most accurately reproduces measurements. For the hybrid method, 79 of 79 DMLC field calculations have gamma < 1 (3%/3 mm) for more than 95% of the points (per field) while for SMLC fields, 27 of 29 pass the same criteria. The analytic energy fluence estimation methods show inferior pass rates, with 76 of 79 DMLC and 24 of 29 SMLC fields having more than 95% of the test points with gamma < or = 1 (3%/3 mm). Paired one-way ANOVA tests of the gamma analysis results found that the hybrid method better predicts measurements in terms of both the fraction of points with gamma < or = 1 and the average gamma for both 2%/2 mm and 3%/3 mm criteria. These results quantify the enhancement in accuracy in IMRT dose calculations when MC is used to model the MLC field modulation.

Entities:  

Mesh:

Year:  2006        PMID: 16696458      PMCID: PMC2621101          DOI: 10.1118/1.2178449

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  29 in total

1.  The MLC tongue-and-groove effect on IMRT dose distributions.

Authors:  J Deng; T Pawlicki; Y Chen; J Li; S B Jiang; C M Ma
Journal:  Phys Med Biol       Date:  2001-04       Impact factor: 3.609

Review 2.  Intensity-modulated radiotherapy: current status and issues of interest.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-15       Impact factor: 7.038

3.  A Monte Carlo study of radiation transport through multileaf collimators.

Authors:  J O Kim; J V Siebers; P J Keall; M R Arnfield; R Mohan
Journal:  Med Phys       Date:  2001-12       Impact factor: 4.071

4.  Monte Carlo simulation of a dynamic MLC based on a multiple source model.

Authors:  M K Fix; P Manser; E J Born; R Mini; P Rüegsegger
Journal:  Phys Med Biol       Date:  2001-12       Impact factor: 3.609

Review 5.  Quality assurance of intensity-modulated radiotherapy.

Authors:  Daniel A Low
Journal:  Semin Radiat Oncol       Date:  2002-07       Impact factor: 5.934

6.  A Monte Carlo based phase space model for quality assurance of intensity modulated radiotherapy incorporating leaf specific characteristics.

Authors:  Randi F Aaronson; John J DeMarco; Indrin J Chetty; Timothy D Solberg
Journal:  Med Phys       Date:  2002-12       Impact factor: 4.071

7.  A method for photon beam Monte Carlo multileaf collimator particle transport.

Authors:  Jeffrey V Siebers; Paul J Keall; Jong Oh Kim; Radhe Mohan
Journal:  Phys Med Biol       Date:  2002-09-07       Impact factor: 3.609

8.  Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine.

Authors:  James M Galvin; Gary Ezzell; Avraham Eisbrauch; Cedric Yu; Brian Butler; Ying Xiao; Isaac Rosen; Julian Rosenman; Michael Sharpe; Lei Xing; Ping Xia; Tony Lomax; Daniel A Low; Jatinder Palta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

9.  A method of simulating dynamic multileaf collimators using Monte Carlo techniques for intensity-modulated radiation therapy.

Authors:  H H Liu; F Verhaegen; L Dong
Journal:  Phys Med Biol       Date:  2001-09       Impact factor: 3.609

10.  Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results.

Authors:  Qiuwen Wu; Radhe Mohan; Monica Morris; Andrew Lauve; Rupert Schmidt-Ullrich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

View more
  3 in total

1.  Generation of a novel phase-space-based cylindrical dose kernel for IMRT optimization.

Authors:  Hualiang Zhong; Indrin J Chetty
Journal:  Med Phys       Date:  2012-05       Impact factor: 4.071

2.  Evaluation of dose prediction errors and optimization convergence errors of deliverable-based head-and-neck IMRT plans computed with a superposition/convolution dose algorithm.

Authors:  I B Mihaylov; J V Siebers
Journal:  Med Phys       Date:  2008-08       Impact factor: 4.071

3.  Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy.

Authors:  Nesrin Dogan; Ivaylo Mihaylov; Yan Wu; Paul J Keall; Jeffrey V Siebers; Michael P Hagan
Journal:  Radiat Oncol       Date:  2009-06-15       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.